کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2116261 | 1084806 | 2013 | 10 صفحه PDF | دانلود رایگان |
Phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is frequently dysregulated in diffuse large B cell lymphoma (DLBCL) including the favorable germinal centre B-cell (GCB) and the unfavorable activated B-cell (ABC) subtypes. mTOR promotes cap-dependent translation of proteins, like Mcl-1, through inhibitory phosphorylation of the eukaryotic translation initiation factor 4E binding protein 1 (4EBP1). Inhibition of mTOR by RAD001 reduces proliferation but fails to dephosphorylate 4EBP1 and to induce cell death in either DLBCL subtype. In contrast, concurrent inhibition of PI3K and mTOR with NVP-BEZ235 inhibits proliferation, dephosphorylates 4EBP1, and induces cells death, notably more pronounced in CGB cells. Small RNA interference identifies Mcl-1 as a crucial cell death mediator of both DLBCL subtypes. Inhibition of the PI3K/mTOR/4EBP1 by NVP-BEZ235 results in suppression of the cap-dependent translation initiation complex and concomitant downregulation of Mcl-1 in GCB cell lines. In ABC cell lines, this suppression is possibly compensated by NF-κB- or Pim kinase-mediated signaling.
► Role of PI3-kinase/Akt/mTOR signaling in diffuse large B cell lymphoma (DLBCL).
► Mcl-1 downregulation facilitates cell death in DLBCL of the ABC and GCB subtype.
► Dual inhibition of PI3K and mTOR induces cell death mainly in GCB DLBCL.
► Mcl-1 expression is decreased only in GCB DLBCL after dual inhibition of PI3K and mTOR.
Journal: Cancer Letters - Volume 339, Issue 2, 10 October 2013, Pages 288–297